US and PRC anti-bribery laws: regulation, risk and prevention in the life sciences industries

Resource type: Articles: know-how

Status: Law stated as at 01-Sep-2007

Jurisdiction: USA

This chapter examines the relevant anti-bribery laws of both the US and China applicable to companies in the life sciences industry. It includes a summary of the Foreign Corrupt Practices Act, the PRC anti-bribery laws and life sciences-specific laws, and outlines specific corruption risks faced in emerging markets such as China where the public healthcare systems are largely controlled by the government. The article also sets out best practices for anti-bribery compliance for life sciences companies, to reduce the risk of corruption violations when doing business in these markets.

Paul V Gerlach, Leslie Shubert and Tang Zhengyu, Sidley Austin

Free trial

New users may access this content by requesting a free, no-obligation trial to our services. To trial please register below, telephone +44 (0)20 7202 1220 or e-mail info@practicallaw.com.

A free trial will give you:

✔	Access to a vast bank of maintained precedents
✔	Daily, weekly and monthly e-mail updates across practice areas of your choice
✔	Practical guidance on the law, applied to situations you face daily
	Register

Log in

Subscribers and those on trial may access this content by logging in below.

Contact Us

If you would like help, please contact the PLC Helpline or see our Help page.

© Practical Law Publishing Limited 1990-2012 (http://www.practicallaw.com/0-207-4980). Terms of use (http://www.practicallaw.com/9-103-0884) and privacy policy (http://www.practicallaw.com/jsp/privacy.jsp). Subscription enquiries +44 (0)20 7202 1220 or email subscriptions@practicallaw.com The reference after links to resources on our site (e.g. 2-123-4567) is to the PLC Reference ID. This will include any PDF or Word versions of articles.